While the majority (62%) dont provide coverage, others are taking or considering a range of actions, from prior authorization to covering the drugs only for members with certain BMIs
Some key findings from the report include: More than 150 GLP-1 drug candidates, intended for the treatment of multiple indications, are currently either approved or being investigated by pharmaceutical companies
You wont need to schedule an office visit or line up at the pharmacy
Most of these are gastrointestinal in nature and are often influenced by food choices
Enter semaglutide , a groundbreaking medication thats been making waves in the weight loss arena
For example, Cognizin has been the subject of several studies to improve cognitive impairment, including one in which 500mg/day resulted in improvements on numerous memory tests over placebo.5 In another study, 500mg and 2,000mg of Cognizin improved brain ATP levels and increased the speed of brain membrane formation.103 The closest thing to this currently on the market is Revive Brain+, which recently reformulated to include PQQ and branded Cognizin citicoline